We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Nykode

News List

Nykode Therapeutics Selects BioConnection to Manufacture Lead Vax Candidate ContractPharma
December 01, 2021
BioConnection, an independent CDMO based in The Netherlands, specialized in GMP -certified manufacturing of sterile drug products in vials and syringes, has announced that Nykode Therapeutics AS...
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron Pharmaceutical-Technology
November 25, 2021
Norwegian vaccine and immunotherapy-focused biopharma Nykode Therapeutics started off in 2007 as Vaccibody, before rebranding this week to signal its significant growth and transformation plans.
Nykode Therapeutics partners with Regeneron to develop cancer and infectious disease vaccines PharmaTimes
November 24, 2021
Nykode Therapeutics, a clinical-stage biopharmaceutical company, announced that it has entered into a collaboration agreement with Regeneron.